ID   GUC2F_HUMAN             Reviewed;        1108 AA.
AC   P51841; Q9UJF1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   02-NOV-2010, entry version 107.
DE   RecName: Full=Retinal guanylyl cyclase 2;
DE            Short=RETGC-2;
DE            EC=4.6.1.2;
DE   AltName: Full=Guanylate cyclase 2F, retinal;
DE   AltName: Full=Guanylate cyclase F;
DE            Short=GC-F;
DE   AltName: Full=Rod outer segment membrane guanylate cyclase 2;
DE            Short=ROS-GC2;
DE   Flags: Precursor;
GN   Name=GUCY2F; Synonyms=GUC2F, RETGC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-296.
RC   TISSUE=Retina;
RX   MEDLINE=95296345; PubMed=7777544; DOI=10.1073/pnas.92.12.5535;
RA   Lowe D.G., Dizhoor A.M., Liu K., Gu Q., Spencer M., Laura R., Lu L.,
RA   Hurley J.B.;
RT   "Cloning and expression of a second photoreceptor-specific membrane
RT   retina guanylyl cyclase (RetGC), RetGC-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5535-5539(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-10.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-40; ASN-160; TRP-230; PRO-284;
RP   GLN-305; CYS-308; HIS-380; ARG-434; ASP-568; GLN-628; LEU-677;
RP   LYS-794; VAL-1010; ARG-1052 AND ASP-1055.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably plays a specific functional role in the rods
CC       and/or cones of photoreceptors. It may be the enzyme involved in
CC       the resynthesis of cGMP required for recovery of the dark state
CC       after phototransduction.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Retina. Localized exclusively in the outer
CC       nuclear layer and inner segments of the rod and cone photoreceptor
CC       cells.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: There are 9 conserved cysteine residues in sensory guanylate
CC       cyclases, 6 in the extracellular domain, which may be involved in
CC       intra- or interchain disulfide bonds.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family.
CC   -!- SIMILARITY: Contains 1 guanylate cyclase domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Mutations of the GUCY2F gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.com/sci-news/gcmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L37378; AAA74451.1; -; mRNA.
DR   EMBL; AL031387; CAB41303.1; -; Genomic_DNA.
DR   IPI; IPI00020942; -.
DR   PIR; I59385; I59385.
DR   RefSeq; NP_001513.2; -.
DR   UniGene; Hs.123074; -.
DR   ProteinModelPortal; P51841; -.
DR   SMR; P51841; 53-454, 531-808, 568-838, 878-1064.
DR   STRING; P51841; -.
DR   PRIDE; P51841; -.
DR   Ensembl; ENST00000218006; ENSP00000218006; ENSG00000101890.
DR   GeneID; 2986; -.
DR   KEGG; hsa:2986; -.
DR   UCSC; uc004eod.2; human.
DR   CTD; 2986; -.
DR   GeneCards; GC0XM108616; -.
DR   H-InvDB; HIX0056276; -.
DR   HGNC; HGNC:4691; GUCY2F.
DR   HPA; HPA000734; -.
DR   HPA; HPA027473; -.
DR   MIM; 300041; gene.
DR   PharmGKB; PA29071; -.
DR   eggNOG; prNOG13804; -.
DR   HOGENOM; HBG714686; -.
DR   HOVERGEN; HBG098487; -.
DR   InParanoid; P51841; -.
DR   BRENDA; 4.6.1.2; 247.
DR   Pathway_Interaction_DB; cone_pathway; Visual signal transduction: Cones.
DR   Pathway_Interaction_DB; rhodopsin_pathway; Visual signal transduction: Rods.
DR   NextBio; 11840; -.
DR   ArrayExpress; P51841; -.
DR   Bgee; P51841; -.
DR   CleanEx; HS_GUCY2F; -.
DR   Genevestigator; P51841; -.
DR   GermOnline; ENSG00000101890; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005640; C:nuclear outer membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR011645; Haem_no_assoc-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   Gene3D; G3DSA:3.30.70.1230; A/G_cyclase; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07701; HNOBA; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF55073; A/G_cyclase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   2: Evidence at transcript level;
KW   cGMP biosynthesis; Complete proteome; Disulfide bond; GTP-binding;
KW   Lyase; Membrane; Nucleotide-binding; Polymorphism;
KW   Sensory transduction; Signal; Transmembrane; Transmembrane helix;
KW   Vision.
FT   SIGNAL        1     50       Potential.
FT   CHAIN        51   1108       Retinal guanylyl cyclase 2.
FT                                /FTId=PRO_0000012386.
FT   TOPO_DOM     51    467       Extracellular (Potential).
FT   TRANSMEM    468    490       Helical; (Potential).
FT   TOPO_DOM    491   1108       Cytoplasmic (Potential).
FT   DOMAIN      532    812       Protein kinase.
FT   DOMAIN      884   1014       Guanylate cyclase.
FT   DISULFID    104    132       By similarity.
FT   DISULFID    452    452       Interchain (By similarity).
FT   DISULFID    460    460       Interchain (By similarity).
FT   VARIANT      10     10       R -> P (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_036419.
FT   VARIANT      40     40       S -> C (in dbSNP:rs34228145).
FT                                /FTId=VAR_042233.
FT   VARIANT     160    160       I -> N (in dbSNP:rs33971675).
FT                                /FTId=VAR_042234.
FT   VARIANT     230    230       R -> W (in dbSNP:rs33973457).
FT                                /FTId=VAR_042235.
FT   VARIANT     284    284       L -> P (in dbSNP:rs12008095).
FT                                /FTId=VAR_009136.
FT   VARIANT     296    296       R -> Q (in dbSNP:rs502209).
FT                                /FTId=VAR_009137.
FT   VARIANT     305    305       R -> Q (in dbSNP:rs55966326).
FT                                /FTId=VAR_042236.
FT   VARIANT     308    308       Y -> C (in dbSNP:rs16985750).
FT                                /FTId=VAR_030633.
FT   VARIANT     380    380       Q -> H (in dbSNP:rs2272925).
FT                                /FTId=VAR_030634.
FT   VARIANT     434    434       G -> R (in dbSNP:rs56293008).
FT                                /FTId=VAR_042237.
FT   VARIANT     568    568       G -> D (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042238.
FT   VARIANT     628    628       R -> Q (in dbSNP:rs7883913).
FT                                /FTId=VAR_030635.
FT   VARIANT     677    677       V -> L (in dbSNP:rs35474112).
FT                                /FTId=VAR_042239.
FT   VARIANT     794    794       E -> K (in dbSNP:rs35726803).
FT                                /FTId=VAR_042240.
FT   VARIANT    1010   1010       A -> V (in dbSNP:rs55735218).
FT                                /FTId=VAR_042241.
FT   VARIANT    1052   1052       K -> R (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042242.
FT   VARIANT    1055   1055       E -> D (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042243.
SQ   SEQUENCE   1108 AA;  124850 MW;  B047BBF1A3C009F9 CRC64;
     MFLGLGRFSR LVLWFAAFRK LLGHHGLASA KFLWCLCLLS VMSLPQQVWT LPYKIGVVGP
     WACDSLFSKA LPEVAARLAI ERINRDPSFD LSYSFEYVIL NEDCQTSRAL SSFISHHQMA
     SGFIGPTNPG YCEAASLLGN SWDKGIFSWA CVNYELDNKI SYPTFSRTLP SPIRVLVTVM
     KYFQWAHAGV ISSDEDIWVH TANRVASALR SHGLPVGVVL TTGQDSQSMR KALQRIHQAD
     RIRIIIMCMH SALIGGETQM HLLECAHDLK MTDGTYVFVP YDALLYSLPY KHTPYRVLRN
     NPKLREAYDA VLTITVESQE KTFYQAFTEA AARGEIPEKL EFDQVSPLFG TIYNSIYFIA
     QAMNNAMKEN GQAGAASLVQ HSRNMQFHGF NQLMRTDSNG NGISEYVILD TNLKEWELHS
     TYTVDMEMEL LRFGGTPIHF PGGRPPRADA KCWFAEGKIC HGGIDPAFAM MVCLTLLIAL
     LSINGFAYFI RRRINKIQLI KGPNRILLTL EDVTFINPHF GSKRGSRASV SFQITSEVQS
     GRSPRLSFSS GSLTPATYEN SNIAIYEGDW VWLKKFSLGD FGDLKSIKSR ASDVFEMMKD
     LRHENINPLL GFFYDSGMFA IVTEFCSRGS LEDILTNQDV KLDWMFKSSL LLDLIKGMKY
     LHHREFVHGR LKSRNCVVDG RFVLKVTDYG FNDILEMLRL SEEESSMEEL LWTAPELLRA
     PRGSRLGSFA GDVYSFAIIM QEVMVRGTPF CMMDLPAQEI INRLKKPPPV YRPVVPPEHA
     PPECLQLMKQ CWAEAAEQRP TFDEIFNQFK TFNKGKKTNI IDSMLRMLEQ YSSNLEDLIR
     ERTEELEIEK QKTEKLLTQM LPPSVAESLK KGCTVEPEGF DLVTLYFSDI VGFTTISAMS
     EPIEVVDLLN DLYTLFDAII GSHDVYKVET IGDAYMVASG LPKRNGSRHA AEIANMSLDI
     LSSVGTFKMR HMPEVPVRIR IGLHSGPVVA GVVGLTMPRY CLFGDTVNTA SRMESTGLPY
     RIHVSLSTVT ILQNLSEGYE VELRGRTELK GKGTEETFWL IGKKGFMKPL PVPPPVDKDG
     QVGHGLQPVE IAAFQRRKAE RQLVRNKP
//
